ALASTAIR THOMPSON to Treatment Outcome
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Treatment Outcome.
Connection Strength
0.368
-
The importance of nonpharmacogenetic factors in endocrine therapy. Pharmacogenomics. 2012 Apr; 13(6):721-8.
Score: 0.091
-
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project. Eur J Cancer. 2018 09; 101:210-219.
Score: 0.035
-
Molecular pathways: preclinical models and clinical trials with metformin in breast cancer. Clin Cancer Res. 2014 May 15; 20(10):2508-15.
Score: 0.026
-
Neoadjuvant treatment of breast cancer. Ann Oncol. 2012 Sep; 23 Suppl 10:x231-6.
Score: 0.023
-
Involved anterior margins after breast conserving surgery: is re-excision required? Eur J Surg Oncol. 2012 Apr; 38(4):302-6.
Score: 0.022
-
Mortality associated with the treatment of gallstone disease: a 10-year contemporary national experience. World J Surg. 2011 Mar; 35(3):643-7.
Score: 0.021
-
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat. 2011 Jan; 125(1):279-87.
Score: 0.020
-
Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy. Br J Cancer. 2010 Jul 13; 103(2):232-8.
Score: 0.020
-
Delay from symptom onset increases the conversion rate in laparoscopic cholecystectomy for acute cholecystitis. World J Surg. 2007 Jun; 31(6):1298-01; discussion 1302-3.
Score: 0.016
-
Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg. 2007 May; 94(5):578-84.
Score: 0.016
-
Patient, carer and health service outcomes of nurse-led early discharge after breast cancer surgery: a randomised controlled trial. Br J Cancer. 2004 Aug 16; 91(4):651-8.
Score: 0.013
-
Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol. BMC Cancer. 2007 Aug 15; 7:160.
Score: 0.008
-
Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer. 2014 Jul 29; 111(3):623-7.
Score: 0.007
-
Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast. Eur J Cancer. 2014 Jul; 50(11):1880-90.
Score: 0.007
-
Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy. Eur J Surg Oncol. 2014 Feb; 40(2):163-7.
Score: 0.006
-
Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer? Br J Cancer. 2013 Nov 26; 109(11):2798-802.
Score: 0.006
-
Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain. 2014 Feb; 155(2):232-243.
Score: 0.006
-
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clin Pharmacol Ther. 2014 Feb; 95(2):216-27.
Score: 0.006
-
The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement. Eur J Surg Oncol. 2012 Feb; 38(2):157-65.
Score: 0.006
-
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell. 2011 Jul 12; 20(1):79-91.
Score: 0.005
-
Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen. J Clin Oncol. 2010 Oct 10; 28(29):e584-5; author reply e586.
Score: 0.005